Tower Research Capital LLC (Trc) Diffusion Pharmaceuticals Inc. Transaction History

Tower Research Capital LLC (Trc)

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$3.34 - $4.7 $3,039 - $4,277	-910 Reduced 27.41%	2,410 $8,000
Q1 2023 May 09, 2023	BUY	$4.15 - $6.6 $2,124 - $3,379	512 Added 18.23%	3,320 $14,000
Q4 2022 Feb 10, 2023	BUY	$4.64 - $6.52 $3,758 - $5,281	810 Added 40.54%	2,808 $14,000
Q3 2022 Nov 10, 2022	BUY	$5.35 - $8.38 $9,378 - $14,690	1,753 Added 715.51%	1,998 $11,000
Q2 2022 Aug 15, 2022	BUY	$5.66 - $14.0 $1,386 - $3,430	245 New	245 $2,000

Ticker DFFN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,039,120
Market Cap $18.9M
Description
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 a...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.